Business Update Conference Call

May 17, 2023 – 8:30 AM ET

Latest Financial Results

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2022

Stock Snapshot

Company Overview

PAVmed Inc. is a highly differentiated, multiproduct medical device company employing a unique business model designed to advance innovative products to commercialization much more rapidly and with significantly less capital than the typical medical device company. This proprietary model enables PAVmed to pursue an expanding pipeline strategy with a view to enhancing and accelerating value creation. PAVmed’s diversified pipeline of products address unmet clinical needs encompassing a broad spectrum of clinical areas with attractive regulatory pathways and market opportunities. Its five lead technologies provide groundbreaking approaches to carpal tunnel syndrome (CarpX™), precancerous conditions of the esophagus (EsoGuard™/EsoCheck™), vascular access (PortIO™), pediatric ear infections (DisappEAR™) and medical infusions (NextFlo™). The company is also developing innovative products in other areas, such as catheters and tissue ablation, while seeking to further expand its pipeline through engagements with clinician innovators and leading academic medical centers.

Investor Contact Information


PAVmed Inc.
One Grand Central Place
Suite 4600
New York, NY 10165
T: 212-949-4319

Investor Relations

Michael Parks
Vice President of Investor Relations
M: 484-356-7105

Transfer Agent

Continental Stock Transfer & Trust Company
17 Battery Place
New York, NY 10004

Market Data copyright © 2023 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.